Quipt Home Medical Corp. reiterated earnings guidance for the fiscal year 2022. For the year, the company is reiterating it outlook for its annual run-rate revenue by the end of calendar 2022 to be $180 million to $190 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 CAD | +0.23% |
|
-3.28% | -34.52% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.52% | 136M | |
+25.33% | 88.38B | |
-23.37% | 77.56B | |
+8.73% | 28.74B | |
+7.45% | 18.45B | |
-15.01% | 16.57B | |
+2.13% | 15.81B | |
+75.59% | 13.65B | |
+80.09% | 13.06B | |
+3.66% | 12.61B |
- Stock Market
- Equities
- QIPT Stock
- News Quipt Home Medical Corp.
- Quipt Home Medical Corp. Reiterates Earnings Guidance for the Fiscal Year 2022